Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
100.00%
↑ 134% above average
Average (39q)
-293.55%
Historical baseline
Range
High:1067.03%
Low:-8873.88%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 100.00% |
| Q2 2025 | -1235.04% |
| Q1 2025 | 109.92% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 100.00% |
| Q4 2023 | -118.68% |
| Q3 2023 | 71.90% |
| Q2 2023 | 121.79% |
| Q1 2023 | 15.25% |
| Q4 2022 | -113.37% |
| Q3 2022 | 1067.03% |
| Q2 2022 | 294.02% |
| Q1 2022 | 136.86% |
| Q4 2021 | -285.15% |
| Q3 2021 | 6.92% |
| Q2 2021 | -26.49% |
| Q1 2021 | 101.79% |
| Q4 2020 | -8873.88% |
| Q3 2020 | 101.07% |
| Q2 2020 | -1765.77% |
| Q1 2020 | 106.70% |
| Q4 2019 | -8.51% |
| Q3 2019 | 18.26% |
| Q2 2019 | -3.67% |
| Q1 2019 | 9.65% |
| Q4 2018 | -20.21% |
| Q3 2018 | -1099.48% |
| Q2 2018 | 108.62% |
| Q1 2018 | -45.38% |
| Q4 2017 | 30.67% |
| Q3 2017 | -559.59% |
| Q2 2017 | 75.53% |
| Q1 2017 | 8.00% |
| Q4 2016 | -6.63% |
| Q3 2016 | -7.54% |
| Q2 2016 | -33.22% |
| Q1 2016 | -4.27% |
| Q4 2015 | -219.22% |